List view / Grid view
8 November 2016 | By Nanosurf
GETec and Nanosurf now offer self-sensing conductive cantilevers for AFSEM™ that enable conductivity probing in the vacuum environment of the SEM...
8 November 2016 | By Nanosurf
Oocysts from the waterborne protozoa Cryptosporidium are micrometer-sized organisms that can be highly infectious...
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Mucosis has begun a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London...
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The US Food and Drug Administration (FDA) accepted Novartis’ new drug application (NDA) for filing and granted priority review for LEE011 (ribociclib)...
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
NICE was reconsidering cetuximab as part of its programme to appraise drugs that are currently available on the Cancer Drugs Fund...
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
New data from a study related to post-meal or postprandial glucose control, show that poor PPG control has a negative impact on diabetics quality of life...
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The MHRA has granted a Promising Innovative Medicine designation for VTS-270, Vtesse’s investigational drug for children with Niemann-Pick Type C1 disease...
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Studies showed that Nyxoid is bioequivalent to injectable naloxone as a first line treatment for opioid overdose, with an intranasal 1.8 mg dose...
3 November 2016 | By BBI Solutions
BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016...
3 November 2016 | By METTLER TOLEDO AG
Pelago Bioscience in Solna, Sweden, is taking advantage of the enhanced process security and convenience offered by METTLER TOLEDO’s Rainin TerraRack™ pipette tip racks...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Olipudase alfa is an enzyme replacement therapy being studied as a treatment of non-neurological manifestations of acid sphingomyelinase deficiency (ASMD)...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Verastem licensed exclusive worldwide rights to develop and commercialise Infinity's oncology product candidate duvelisib...
3 November 2016 | By Wickham Laboratories Limited
Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
NICE has said eribulin, which is also called Halaven and made by Eisai, should be an option for people with locally advanced or metastatic breast cancer...
31 October 2016 | By IFPAC
Emerging technologies to modernize pharmaceutical/biopharmaceutical development and manufacturing...
